Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Johnson and Johnson
McKinsey
Moodys
Boehringer Ingelheim

Last Updated: January 21, 2020

DrugPatentWatch Database Preview

Formulation information for generic ingredient: lixisenatide

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Dulaglutide

CASRN: 923950-08-7

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Dow
Colorcon
Medtronic
McKesson